• Text size      
  • Send this article to a friend
  • Print this article

Omega Diagnostics tipped for £2m sales of HIV test

ANALYSTS have suggested Omega Diagnostics may sell around £2 million of its highly-anticipated HIV test in 2015.

Edison Investment Research said it believes pilot studies for the CD4 test, which sees if white blood cells have fallen to a level where retroviral drug treatment is needed, could start in the first half of next year with "significant sales" in the following 12 months.

The research note also indicates a full launch for Omega's 40 automated allergy tests for the iSYS system used in laboratories around the world may now be in mid-2015.

Edison predicted revenue at Omega in its 2015 financial year will be more than £14m with profit before tax coming in around £2.4m.

The company is expected to post revenue of around £11.5m in the 12 months to March 2014 with profits of £700,000.

Contextual targeting label: 

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.